Valuation: BICO Group AB

Capitalization 1.24B 135M 116M 105M 101M 184M 12.39B 192M 497M 5.94B 506M 495M 21.25B P/E ratio 2025
-1.36x
P/E ratio 2026 * -7.55x
Enterprise value 1.25B 136M 117M 106M 102M 185M 12.49B 194M 501M 5.99B 510M 499M 21.43B EV / Sales 2025
0.99x
EV / Sales 2026 * 0.72x
Free-Float
62.25%
Yield 2025 *
-
Yield 2026 * -
1 day-2.28%
1 week-3.72%
Current month-3.72%
1 month+1.09%
3 months-11.57%
6 months-26.13%
Current year-16.52%
1 week 16.99
Extreme 16.99
18.14
1 month 15.3
Extreme 15.3
18.67
Current year 15.3
Extreme 15.3
21.06
1 year 15.3
Extreme 15.3
42.46
3 years 15.3
Extreme 15.3
72.3
5 years 15.3
Extreme 15.3
630
10 years 9
Extreme 9
630
Manager TitleAgeSince
Chief Executive Officer 54 2023-11-26
Director of Finance/CFO 41 2023-01-01
Director TitleAgeSince
Director/Board Member 73 2015-12-31
Director/Board Member 70 2019-12-17
Director/Board Member 57 2021-11-16
Change 5d. change 1-year change 3-years change Capi.($)
-2.28%-3.72%-56.89%-74.54% 137M
-3.25%-3.67%-4.87%-10.12% 193B
-1.32%-2.65%-8.99%+108.71% 176B
-3.22%-7.19%-8.99%-21.75% 143B
-2.25%-7.16%-29.22%+49.46% 108B
-0.22%-4.11%-23.32%-20.20% 52.25B
-2.68%-5.59%+13.70%+3.60% 48.72B
-0.96%-1.32%+12.37%+15.38% 37.19B
-3.68%-11.87%-13.04%-3.14% 35.14B
-2.57%-5.20%-9.07%-19.66% 33.38B
Average -2.24%-3.75%-12.83%+2.77% 82.71B
Weighted average by Cap. -2.36%-3.99%-9.47%+22.23%

Financials

2025 2026 *
Net sales 1.55B 169M 145M 131M 126M 230M 15.49B 240M 621M 7.43B 633M 619M 26.57B 1.58B 171M 148M 133M 128M 233M 15.74B 244M 631M 7.55B 643M 629M 27B
Net income -1.55B -169M -145M -131M -126M -230M -15.5B -240M -622M -7.43B -633M -620M -26.59B -164M -17.86M -15.4M -13.9M -13.34M -24.32M -1.64B -25.45M -65.82M -787M -67.02M -65.59M -2.81B
Net Debt 10M 1.09M 937K 846K 812K 1.48M 99.88M 1.55M 4.01M 47.9M 4.08M 3.99M 171M -101M -11.02M -9.5M -8.58M -8.23M -15.01M -1.01B -15.71M -40.62M -486M -41.36M -40.48M -1.74B
Logo BICO Group AB
BICO Group AB, previously Cellink AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The Company develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Employees
586
Date Price Change Volume
26-03-06 17.58 kr -2.28% 174,936
26-03-05 17.99 kr +2.45% 623,814
26-03-04 17.56 kr +2.51% 134,117
26-03-03 17.13 kr -4.03% 263,901
26-03-02 17.85 kr -2.25% 228,603
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
17.58SEK
Average target price
30.67SEK
Spread / Average Target
+74.44%

Quarterly revenue - Rate of surprise